BE674919A - - Google Patents

Info

Publication number
BE674919A
BE674919A BE674919DA BE674919A BE 674919 A BE674919 A BE 674919A BE 674919D A BE674919D A BE 674919DA BE 674919 A BE674919 A BE 674919A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE674919A publication Critical patent/BE674919A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BE674919D 1965-01-12 1966-01-10 BE674919A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH41465A CH458365A (de) 1965-01-12 1965-01-12 Verfahren zur Herstellung von neuen Picolylamin-Derivaten

Publications (1)

Publication Number Publication Date
BE674919A true BE674919A (en:Method) 1966-07-11

Family

ID=4186481

Family Applications (1)

Application Number Title Priority Date Filing Date
BE674919D BE674919A (en:Method) 1965-01-12 1966-01-10

Country Status (11)

Country Link
US (1) US3350400A (en:Method)
BE (1) BE674919A (en:Method)
BR (1) BR6676358D0 (en:Method)
CH (1) CH458365A (en:Method)
DE (1) DE1545772B1 (en:Method)
DK (1) DK114482B (en:Method)
ES (1) ES321531A1 (en:Method)
FR (2) FR1463438A (en:Method)
GB (1) GB1084150A (en:Method)
IT (1) IT7830644A0 (en:Method)
NL (2) NL6600250A (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3032554A (en) * 1962-05-01 Process for the preparation of new
US3029239A (en) * 1954-04-17 1962-04-10 Chemiewerk Homburg Zweignieder Basic substituted 1-and 7-alkylxanthines or salts thereof
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen
DE1018869B (de) * 1954-12-14 1957-11-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von Aminoalkylpurinderivaten
DE1112983B (de) * 1958-11-21 1961-08-24 Sandoz Ag Verfahren zur Herstellung von Theophyllin-Derivaten
CH402872A (de) * 1959-12-18 1965-11-30 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von Theophyllin- oder Theobromin-Derivaten

Also Published As

Publication number Publication date
CH458365A (de) 1968-08-30
FR5128M (en:Method) 1967-06-05
BR6676358D0 (pt) 1973-09-06
NL128191C (en:Method)
DE1545772B1 (de) 1969-12-11
FR1463438A (fr) 1966-12-23
GB1084150A (en:Method)
ES321531A1 (es) 1966-11-01
IT7830644A0 (it) 1978-12-06
US3350400A (en) 1967-10-31
NL6600250A (en:Method) 1966-07-13
DK114482B (da) 1969-07-07

Similar Documents

Publication Publication Date Title
JPS4827428B1 (en:Method)
JPS4319759Y1 (en:Method)
JPS455746Y1 (en:Method)
JPS458100Y1 (en:Method)
JPS4211993Y1 (en:Method)
JPS4217192Y1 (en:Method)
JPS4427928Y1 (en:Method)
JPS4419199Y1 (en:Method)
JPS423882Y1 (en:Method)
AU6340065A (en:Method)
NL6613911A (en:Method)
BE661161A (en:Method)
BE674580A (en:Method)
BE666453A (en:Method)
BE673199A (en:Method)
BE672700A (en:Method)
BE666888A (en:Method)
BE671318A (en:Method)
BE674750A (en:Method)
BE667827A (en:Method)
BE672809A (en:Method)
BE672016A (en:Method)
NL6609691A (en:Method)
BE674556A (en:Method)
BE667886A (en:Method)